Skip to content

A randomized, double-blind, placebo-controlled study of collagen tripeptide bioavailability and improvement of skin condition

A randomized, double-blind, placebo-controlled study of collagen tripeptide bioavailability and improvement of skin condition

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069162
Enrollment
Unknown
Registered
2023-03-08
Start date
2023-03-08
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin aging

Interventions

Group 1:Oral collagen tripeptide powder
Group 2:Oral collagen tripeptide and elastin peptide mixed preparation

Sponsors

Institute of Nutrition and Health, Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 55 Years

Inclusion criteria

Inclusion criteria: Healthy women aged 30-55 years; Dry skin on the forearms according to self-assessment; Photo types I-IV (Fitzpatrick scale); Good general health and mental condition; Consent to the trial process and sign the informed consent form; Attend in person at the study group appointment time and be willing and able to adhere to the study rules and flow charts.

Exclusion criteria

Exclusion criteria: Acute skin conditions (such as allergic eczema, neurodermatitis or psoriasis) or other skin conditions (such as scarring, sunburn or moles) in the test skin area; Food allergy to the ingredients of the test product; gastrointestinal disorders or dyspepsia; Test for tattoos on the skin area; Topical administration in the test skin area within 6 weeks prior to study start; systemic use of anti-inflammatory drugs or antibiotics in the 2 weeks prior to study start; systemic administration of corticosteroids and/or antihistamines within 4 weeks prior to study start; other systemic medications within 4 weeks prior to study start; Participants present with systemic illness at the start of the study; Pregnancy or lactation; Immune disorders; severe medical conditions (e.g. cancer, acute cardiac and circulatory disorders, severe diabetes, alcohol or drug abuse) within the six months prior to study start; Participate in other cosmetic trials conducted on the test skin area within 2 weeks prior to or during the study; Participation in the study of pharmaceutical preparations within 4 weeks prior to the start of the study; intake of nutritional supplements (except for the test product) within 4 weeks prior to study start and during the study; changes in lifestyle or eating habits during the study period; treatment with make-up remover products or oily or moisturizing skin cleansers on the arm; changing daily skin care routines; Strong sun exposure or artificial UV exposure (sunbathing) to the test area before the start of the study or for 1 week during the study; swimming, sauna or high-intensity exercise within 1 day prior to measurement; Lack of adherence, intellectual or mental inability to follow study instructions.

Design outcomes

Primary

MeasureTime frame
Skin elasticity;Skin wrinkles;Skin pores;Skin tone;

Secondary

MeasureTime frame
Skin microbiota;Skin metabolites;Fecal microbiota;Fecal metabolites;Blood biochemistry;Urine metabolites;

Countries

China

Contacts

Public ContactJin Sun

Institute of Nutrition and Health, Qingdao University

sunj@qdu.edu.cn18151559959

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026